Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
2,932.40
|
|
Change (%)
|
27.55 (0.95%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
2,826.60
-
2,969.85
|
|
52-Week Range (RS)
|
1,575.00
-
3,039.00
|
|
Beta (1 Year)
|
0.56
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE Midcap |
| News |
|
Corporate Details |
| Volumes jump at HBL Engineering Ltd counter |
| Volumes jump at Gland Pharma Ltd counter |
| Volumes jump at Vardhman Textiles Ltd counter |
| Gland Pharma appoints Deepak Sapra as CEO |
| Volumes soar at Gland Pharma Ltd counter |
| Benchmarks trade in positive terrain; realty shares jump |
| Gland Pharma rises after signing strategic CDMO pact with global pharmaceutical firm |
| Gland Pharma consolidated net profit rises 47.09% in the June 2026 quarter |
| Gland and Neuland Lab announces long term strategic CDMO partnership |
| Gland Pharma gains after USFDA approves generic Sugammadex Injection |
|
|
|
| Incoporation Year : 1978 |
| Chairman : SRINIVAS SADU |
| Ownership Group : MNC Associate |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Formulations |
| Registered Office |
Gland Pharma Ltd
Sy No 143-148 150&151 Nr Gandi,
X Roads D P Pally Dundigal,
Hyderabad,
Telangana-500043 |
Phone:91-40-30510999
Fax:91-40-30510800 |
| E-Mail : investors@glandpharma.com |
| URL : http://www.glandpharma.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
28-Aug-2026 |
2886.05 |
1.61 |
| 1Month |
04-Aug-2026 |
2580.80 |
13.62 |
| 3Month |
04-Jun-2026 |
2220.90 |
32.04 |
| 6Month |
04-Mar-2026 |
1709.50 |
71.54 |
| 1Year |
04-Sep-2025 |
1887.25 |
55.38 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Mid Cap Fund |
1.44 |
1518.71 |
| SBI Large & Midcap Fund |
1.87 |
793.42 |
| Nippon India Growth Mid Cap Fund |
1.38 |
700.81 |
| Mirae Asset Large & Midcap Fund |
1.36 |
614.55 |
| ICICI Pru India Opportunities Fund |
1.57 |
601.55 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
4,850.00 |
-1.52 |
5,249.95 |
3,480.00 |
184,478.41 |
| Ajanta Pharma Ltd |
3,464.45 |
-1.61 |
3,796.95 |
2,335.00 |
43,291.43 |
| Rubicon Research Ltd |
1,773.25 |
-0.05 |
1,896.15 |
571.00 |
29,352.95 |
| Caplin Point Laboratories Ltd |
2,810.25 |
-1.14 |
2,874.00 |
1,502.45 |
21,361.19 |
| Shilpa Medicare Ltd |
964.95 |
0.95 |
974.90 |
260.00 |
18,872.67 |
|
|
|
|